Abstract:Mei Li, 1 Jing Xu, 1, 2 Yujue Wang, 1 Xiaoye Du, 1, 2 Teng Zhang, 1, 2 Yu Chen 1– 3 1 Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200427, People's Republic of China; 2 Clinical Research Institute of Integrative Medicine, Shanghai Academy of Traditional Chinese Medicine, Shanghai, 200437, People's Republic of China; 3 Laboratory of Clinical and Molecular Pharmacology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200427, People's Republic of China Correspondence: Yu Chen, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, 110 Ganhe Road, Shanghai, 200437, People's Republic of China, Tel +86 21 5598 1009, Fax +86 21 5598 1009, Email Purpose: Photoreceptors are specialized retinal neurons responsible for phototransduction. Loss of photoreceptors directly leads to irreversible vision impairment. Pharmacological therapies protecting against photoreceptor degeneration are clinically lacking. Oxidative stress and inflammation are common mechanisms playing important roles in the pathogenesis of photoreceptor degeneration. Astragaloside A (AS-A) is a naturally occurring antioxidant and anti-inflammatory agent with neuroprotective activities. However, the photoreceptor protective effects of AS-A remain unknown. The current study thus aims to illustrate the pharmacological potentials of AS-A in protecting against photoreceptor degeneration. Methods: BALB/c and C57/BL6J mice were exposed to bright light and DNA alkylating agent methyl methanesulfonate (MMS) to develop oxidative stress and DNA damage-mediated photoreceptor degeneration, respectively. Microstructural, morphological and functional assessments were performed to directly evaluate the photoreceptor protective effects of AS-A. Ultrastructural and molecular changes in the retina were examined to better understand the pharmacological mechanisms of AS-A in protecting against photoreceptor degeneration. Results: AS-A protected against bright light-induced photoreceptor impairment. Bright light-induced retinal oxidative stress and photoreceptor cell death were attenuated by AS-A treatment. AS-A treatment mitigated bright light-induced DNA damage, activation of poly (ADP-ribose) polymerase (PARP) and nuclear dislocation of high mobility group box 1 (HMGB1) in photoreceptors. AS-A broadly counteracted bright light-altered retinal gene expression profiles. In particular, AS-A decreased the retinal expression of genes involved in necroptosis and inflammatory responses. Bright light-induced microglial activation was also suppressed as a result of AS-A treatment. Furthermore, AS-A attenuated MMS-induced photoreceptor morphological impairment, elevated expression of pro-necroptotic and proinflammatory genes as well as microglial activation in the retina. Conclusion: The work here demonstrates for the first time that AS-A protects against photoreceptor degeneration in part through mitigating oxidative stress and DNA damage-induced necroptosis and inflammatory responses in the retina. Keywords: retinal degeneration, photooxidative stress, photoreceptor protection, programmed cell death, microglial activation Photoreceptors are the first-order retinal neurons that carry out light detection and phototransduction functions, playing an essential role in initiating vision. 1 Photoreceptor degeneration is responsible for irreversible and progressive vision impairment in patients with age-related macular degeneration (AMD) and inherited retinal degeneration such as retinitis pigmentosa. 2,3 A number of therapies have been evaluated in clinical trials and proven to be either ineffective or inconclusive regarding the efficacy to prevent the loss of photoreceptors in dry AMD. Ongoing clinical trials are also available for the treatment of dry AMD. However, proper photoreceptor protective therapies have not been officially approved for clinical usage to prevent or delay the progression of photoreceptor degeneration. 4 Photoreceptor degenerative disorders can be caused by mutations in the functional genes, environmental insults or a combination of both genetic and environmental factors. Regardless of the etiologies, programmed cell death triggered by oxidative stress is a common mechanism underlying the loss of photoreceptors. 5 Moreover, photoreceptor degeneration is often accompanied and further aggravated by excessive inflammatory responses primarily mediated by activated microglial cel -Abstract Truncated-

Suppressing endoplasmic reticulum stress-related autophagy attenuates retinal light injury

Inhibiting the Activation of MAPK (ERK1/2) in Stressed Müller Cells Prevents Photoreceptor Degeneration

Light-Induced Retinal Ganglion Cell Damage and the Relevant Mechanisms

Illumination from Light-Emitting Diodes (leds) Disrupts Pathological Cytokines Expression and Activates Relevant Signal Pathways in Primary Human Retinal Pigment Epithelial Cells.

Protective effects of autophagy against blue light-induced retinal degeneration in aged mice

Retinal light damage: From mechanisms to protective strategies

Autophagy in Age-Related Macular Degeneration: A Regulatory Mechanism of Oxidative Stress

Involvement of endoplasmic reticulum stress in all-trans-retinal-induced retinal pigment epithelium degeneration.

Autophagy in Light-Induced Retinal Damage

The Role of Oxidative Stress and Autophagy in Blue-Light-Induced Damage to the Retinal Pigment Epithelium in Zebrafish In Vitro and In Vivo

Protective effect of autophagy on human retinal pigment epithelial cells against lipofuscin fluorophore A2E: implications for age-related macular degeneration

Long-term Blue Light Exposure Impairs Mitochondrial Dynamics in the Retina in Light-Induced Retinal Degeneration in Vivo and in Vitro

Oxidative Stress and Mitochondrial Dysfunction of Retinal Ganglion Cells Injury Exposures in Long-Term Blue Light.

Oxidative stress induces autophagy in response to multiple noxious stimuli in retinal ganglion cells

Maintaining KEAP1 levels in retinal pigment epithelial cells preserves their viability during prolonged exposure to artificial blue light

Astragaloside A Protects Against Photoreceptor Degeneration in Part Through Suppressing Oxidative Stress and DNA Damage-Induced Necroptosis and Inflammation in the Retina

Effect of Phosphorylated-Extracellular Regulated Kinase 1/2 Inhibitor on Retina from Light-induced Photoreceptor Degeneration

The potential effects of nutrients and light on autophagy-mediated visual function and clearance of retinal aggregates

Rapamycin Inhibits Light-Induced Necrosome Activation Occurring in Wild-Type, but not RPE65-Null, Mouse Retina

Knockout of Ccr2 alleviates photoreceptor cell death in rodent retina exposed to chronic blue light

Shifting the balance of autophagy and proteasome activation reduces proteotoxic cell death: a novel therapeutic approach for restoring photoreceptor homeostasis